These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
98 related articles for article (PubMed ID: 7719718)
1. Further studies on the effects of chronic clozapine on regional extracellular dopamine levels in the brain of conscious rats. Invernizzi R; Pozzi L; Samanin R Brain Res; 1995 Jan; 670(1):165-8. PubMed ID: 7719718 [TBL] [Abstract][Full Text] [Related]
2. Effects of acute and chronic clozapine on dopamine release and metabolism in the striatum and nucleus accumbens of conscious rats. Invernizzi R; Morali F; Pozzi L; Samanin R Br J Pharmacol; 1990 Aug; 100(4):774-8. PubMed ID: 2207499 [TBL] [Abstract][Full Text] [Related]
3. Clozapine-induced dopamine levels in the rat striatum and nucleus accumbens are not affected by muscarinic antagonism. Gray AM; Connick JH Eur J Pharmacol; 1998 Dec; 362(2-3):127-36. PubMed ID: 9874162 [TBL] [Abstract][Full Text] [Related]
4. Dopamine release and metabolism in the rat frontal cortex, nucleus accumbens, and striatum: a comparison of acute clozapine and haloperidol. Karoum F; Egan MF Br J Pharmacol; 1992 Mar; 105(3):703-7. PubMed ID: 1628156 [TBL] [Abstract][Full Text] [Related]
5. The effect of chronic clozapine on basal dopamine release and apomorphine-induced DA release in the striatum and nucleus accumbens as measured by in vivo brain microdialysis. Chai B; Meltzer HY Neurosci Lett; 1992 Jun; 140(1):47-50. PubMed ID: 1383891 [TBL] [Abstract][Full Text] [Related]
6. The effect of chronic clozapine and haloperidol on basal dopamine release and metabolism in rat striatum and nucleus accumbens studied by in vivo microdialysis. Ichikawa J; Meltzer HY Eur J Pharmacol; 1990 Feb; 176(3):371-4. PubMed ID: 2184042 [TBL] [Abstract][Full Text] [Related]
7. 3-Methoxytyramine is the major metabolite of released dopamine in the rat frontal cortex: reassessment of the effects of antipsychotics on the dynamics of dopamine release and metabolism in the frontal cortex, nucleus accumbens, and striatum by a simple two pool model. Karoum F; Chrapusta SJ; Egan MF J Neurochem; 1994 Sep; 63(3):972-9. PubMed ID: 7914228 [TBL] [Abstract][Full Text] [Related]
8. Effects of acute and chronic clozapine on dopaminergic function in medial prefrontal cortex of awake, freely moving rats. Chen JP; Ruan D; Paredes W; Gardner EL Brain Res; 1992 Feb; 571(2):235-41. PubMed ID: 1611497 [TBL] [Abstract][Full Text] [Related]
9. Selective reduction of extracellular dopamine in the rat nucleus accumbens following chronic treatment with DAU 6215, a 5-HT3 receptor antagonist. Invernizzi R; Pozzi L; Samanin R Neuropharmacology; 1995 Feb; 34(2):211-5. PubMed ID: 7617146 [TBL] [Abstract][Full Text] [Related]
10. Effect of scopolamine on the efflux of dopamine and its metabolites after clozapine, haloperidol or thioridazine. Meltzer HY; Chai BL; Thompson PA; Yamamoto BK J Pharmacol Exp Ther; 1994 Mar; 268(3):1452-61. PubMed ID: 8138957 [TBL] [Abstract][Full Text] [Related]
11. Dopamine and 5-HT turnover are increased by the mGlu2/3 receptor agonist LY379268 in rat medial prefrontal cortex, nucleus accumbens and striatum. Cartmell J; Salhoff CR; Perry KW; Monn JA; Schoepp DD Brain Res; 2000 Dec; 887(2):378-84. PubMed ID: 11134627 [TBL] [Abstract][Full Text] [Related]
12. Chronic clozapine selectively decreases prefrontal cortex dopamine as shown by simultaneous cortical, accumbens, and striatal microdialysis in freely moving rats. Hernandez L; Hoebel BG Pharmacol Biochem Behav; 1995 Nov; 52(3):581-9. PubMed ID: 8545478 [TBL] [Abstract][Full Text] [Related]
13. Differential effects of repeated treatment with haloperidol and clozapine on dopamine release and metabolism in the striatum and the nucleus accumbens. Ichikawa J; Meltzer HY J Pharmacol Exp Ther; 1991 Jan; 256(1):348-57. PubMed ID: 1703232 [TBL] [Abstract][Full Text] [Related]
14. Intracerebroventricular administration of substance P increases dopamine content in the brain of 6-hydroxydopamine-lesioned rats. Krasnova IN; Bychkov ER; Lioudyno VI; Zubareva OE; Dambinova SA Neuroscience; 2000; 95(1):113-7. PubMed ID: 10619467 [TBL] [Abstract][Full Text] [Related]
15. Differential effect of stress on in vivo dopamine release in striatum, nucleus accumbens, and medial frontal cortex. Abercrombie ED; Keefe KA; DiFrischia DS; Zigmond MJ J Neurochem; 1989 May; 52(5):1655-8. PubMed ID: 2709017 [TBL] [Abstract][Full Text] [Related]
16. JL13, a pyridobenzoxazepine compound with potential atypical antipsychotic activity, increases extracellular dopamine in the prefrontal cortex, but not in the striatum and the nucleus accumbens of rats. Invernizzi R; Garavaglia C; Samanin R Naunyn Schmiedebergs Arch Pharmacol; 2000 Mar; 361(3):298-302. PubMed ID: 10731043 [TBL] [Abstract][Full Text] [Related]
17. Chronic treatment with clozapine selectively decreases basal dopamine release in nucleus accumbens but not in caudate-putamen as measured by in vivo brain microdialysis: further evidence for depolarization block. Chen JP; Paredes W; Gardner EL Neurosci Lett; 1991 Jan; 122(1):127-31. PubMed ID: 2057129 [TBL] [Abstract][Full Text] [Related]
18. Differential effects of amfonelic acid on the haloperidol- and clozapine-induced increase in extracellular DOPAC in the nucleus accumbens and the striatum. Rivest R; Marsden CA Synapse; 1992 Jan; 10(1):71-8. PubMed ID: 1371367 [TBL] [Abstract][Full Text] [Related]
19. Differences in dopamine release and metabolism in rat striatal subregions following acute clozapine using in vivo microdialysis. O'Connor WT; Drew KL; Ungerstedt U Neurosci Lett; 1989 Mar; 98(2):211-6. PubMed ID: 2710415 [TBL] [Abstract][Full Text] [Related]
20. Haloperidol given chronically decreases basal dopamine in the prefrontal cortex more than the striatum or nucleus accumbens as simultaneously measured by microdialysis. Hernandez L; Hoebel BG Brain Res Bull; 1989 Apr; 22(4):763-9. PubMed ID: 2736403 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]